Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Wandering Nerve: Gateway to Boost Alzheimer's Disease Related Cognitive

NCT04908358 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04908358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04908358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Wandering Nerve: Gateway to Boost Alzheimer's Disease Related Cognitive
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 24, 2021
Completion date
August 25, 2026
Enrollment
126 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aging